<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               7 DRUG INTERACTIONS<BR>               <BR>                  <BR><BR>                  <BR>                     Tamoxifen<BR>                  <BR>                  <BR> <BR>Coadministration of letrozole tablets and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels of 38% on average. Clinical experience in the second-line breast cancer trials indicates that the therapeutic effect of letrozole tablets therapy is not impaired if letrozole tablets are administered immediately after tamoxifen.<BR> <BR><BR>                  <BR>                     Cimetidine<BR>                  <BR>                  <BR> <BR>A pharmacokinetic interaction study with cimetidine showed no clinically significant effect on letrozole pharmacokinetics.<BR> <BR><BR>                  <BR>                     Warfarin<BR>                  <BR>                  <BR> <BR>An interaction study with warfarin showed no clinically significant effect of letrozole on warfarin pharmacokinetics.<BR> <BR><BR>                  <BR>                     Other anticancer agents<BR>                  <BR>                  <BR> <BR>There is no clinical experience to date on the use of letrozole tablets in combination with other anticancer agents.<BR>               <BR>            <BR>         </P></DIV></HTML>